History of human papillomavirus, warts and cancer: What do we know today?

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 25, Issue 5, 2011, Pages 565-574

  Onon, Toli S ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cervical cancer; Genital warts; Human papillomavirus; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; CANCER IMMUNIZATION; CONDYLOMA ACUMINATUM; HISTORY OF MEDICINE; HUMAN; INFECTION PREVENTION; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS ETIOLOGY; WART VIRUS; ALPHAPAPILLOMAVIRUS; FEMALE; HISTORY; PATHOGENICITY; UTERINE CERVIX TUMOR; VIROLOGY;

ALPHAPAPILLOMAVIRUS; CONDYLOMATA ACUMINATA; FEMALE; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HISTORY, ANCIENT; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS;

EID: 84858244002     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2011.05.001     Document Type: Review

References (41)

1. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003; 16: 1-17. (Pubitemid 36114705)
2. Hildesheim A. Human papillomavirus variants: implications for natural history studies and vaccine development efforts. J Natl Cancer Inst 1997; 89: 752-753.
3. McCaffery M. Autopsy of a mummy - warts and all. Can Fam Physician 1974; 20: 89-91.
4. Wahlkvist H, Masjedi K, Gruvberger B et al. The lipophilic hapten parthenolide induces interferon-gamma and interleukin- 13 production by peripheral blood-derived CD8+ T cells from contact allergic subjects in vitro. Br J Dermatol 2008; 158: 70-77. (Pubitemid 350221916)
5. Celsus AC. De Medicina. AD25. Translated by Spencer WG. Loeb Classical Library 1938.
6. Burns DA. 'Warts and all' - the history and folklore of warts: a review. J R Soc Med 1992; 85: 37-40.
7. Doorbar J. Warts and all. Mill Hill Essays 1999. MRC National Institute for Medical Research; http://www.nimr.mrc.ac.uk/mill-hill-essays/warts-and-all (last accessed 08 05 2011).
8. Claude Moore Health Sciences Library. Surgical instruments from Ancient Rome http://www.hsl.virginia.edu/historical/artifacts/roman-surgical/ (last accessed 08 05 2011).
9. Franco G & Franco F. Bernardo Ramazzini: the father of occupational medicine. Am J Public Health 2001; 91: 1382.
10. Scotto J & Bailar JC. Rigoni-Stern and medical statistics. A nineteenth-century approach to cancer research. J Hist Med Allied Sci 1969: 65-75. XXIV.
11. Rotkin ID. A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res 1973; 33: 1353-1367.
12. Gagnon F. Contribution to the study of the etiology and prevention of cancer of the cervix of the uterus. Am J Obstet Gynecol 1950; 50: 516-522.
13. Payne JF. On the contagiousness of common warts. Br J Dermatol 1891; 3: 185-188.
14. Ciuffo G. Innesto positivo con filtrato di verruca volgare. G Ital Mal Venereal 1907; 42: 12-17.
15. Strauss MJ, Bunting H & Melnick JL. Virus-like particles and inclusion bodies in skin papillomas. J Invest Dermatol 1950; 15: 433-444.
16. Van Epps HL. Peyton Rous: father of the tumor virus. J Exp Med 2005; 201: 320. (Pubitemid 40229405)
17. Shope R. Infectious papillomatosis of rabbits. J Exp Med 1933; 58: 607-624.
18. Rous P & Beard JW. The progression to carcinoma of virus-induced rabbit papillomas (Shope). J Exp Med 1935; 62: 523-548.
19. Burnet M. Cancer: a Biological Approach. III Viruses associated with neoplastic conditions. BMJ 1957; 1: 841-847.
20. Epstein MA, Achong BG & Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; 1: 702-703.
21. Klein G. Summary of papers delivered at the American Cancer Society Conference on Herpesvirus and Cervical Cancer (Key Biscayne, Florida). Cancer Res 1973; 33: 1557-1563.
22. McIntyre P. Finding the viral link: the story of Harald zur Hausen. Cancer World 2005: 32-37. Jul-Aug.
23. zur Hausen H. Condylomata acuminate and human genital cancer. Cancer Res 1976; 36: 794.
24. Gissmann L, Pfister H & zur Hausen H. Human papilloma viruses (HPV): characterization of 4 different isolates. Virology 1977; 76: 569-580. (Pubitemid 8078755)
25. Orth G, Favre M & Croissant O. Characterization of a new type of human papillomavirus that causes skinwarts. J Virol 1977; 24: 108-120. (Pubitemid 8190844)
26. Durst M, Gissmann L, Ikenberg H et al. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983; 80: 3812-3815. (Pubitemid 13063146)
27. Munoz N, Bosch FX, de Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527. (Pubitemid 36159887)
28. Wieland U & Pfister H. Papillomaviruses in human pathology: epidemiology, pathogenesis and oncogenic role. In Gross GE & Barrasso R (eds.). Human papilloma virus infection: a clinical atlas. Berlin: Ullstein Mosby GmbH & Co. KG, 1997, pp. 1-18.
29. Borysiewicz LK, Fiander A, Nimako M et al. A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet 1996; 347: 1523-1527. (Pubitemid 26162644)
30. Kaufmann AM, Stern PL, Rankin EM et al. Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer. Clin Cancer Res 2002; 8: 3676-3685. (Pubitemid 35424757)
31. Zhou J, Sun XY, Stenzel DJ et al. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 1991; 185: 251-257.
32. Bosch FX, Manos MM, Munoz N et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995; 87: 796-802.
33. IARC Working Group. Monograph on the evaluation of carcinogenic risks to humans. In: Human Papillomaviruses 1995; vol. 64. Lyon: IARC Scientific Publications, 1995.
34. Walboomers JMM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer world-wide. J Path 1999; 189: 12-19. (Pubitemid 29406813)
35. Crook T & Vousden KH. HPV oncoprotein function. In Lacey C (ed.). Papillomavirus Reviews: Current research on papillomaviruses. Leeds: Leeds University Press, 1996, pp. 55-60.
36. zur Hausen H. Cervical cancer and human papillomavirus: on the road to preventing a major human cancer. J Natl Cancer Inst 2001; 93: 252-253.
37. Bosch FX, Munoz N, de Sanjose S et al. Comment on: Cervical cancer and human papillomavirus: on the road to preventing a major human cancer. J Natl Cancer Inst 2001; 93: 1349.
38. zur Hausen H. Comment on: Cervical cancer and human papillomavirus: on the road to preventing a major human cancer. J Natl Cancer Inst 2001; 93: 1350.
39. Canfell K. Monitoring HPV vaccination programmes. BMJ 2010; 340: 667-668.
40. Baseman JG & Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol 2005; 32S: S16-S24. (Pubitemid 40332585)
41. Saslow D, Castle PE, Cox JT et al. American Cancer Society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 2007; 57: 7-28. (Pubitemid 46148088)